Building a new path to make medicines with AI
Isomorphic Labs is leveraging advanced AI foundation models to transform drug discovery into a systematic engineering discipline. The company aims to design precisely engineered molecules by integrating data generation, model training, and clinical development under one roof. This approach seeks to overcome traditional bottlenecks in medicine creation to accelerate the delivery of effective treatments to patients.
- ▪Isomorphic Labs was founded in 2021 to apply breakthroughs in AI to the complex challenge of drug discovery.
- ▪The company utilizes a vertically integrated model that handles everything from AI model development and data generation to clinical trials.
- ▪AI foundation models are employed to predict molecular properties and design therapeutics with high precision and minimal toxicity.
- ▪The initiative involves a multidisciplinary team of AI researchers, biologists, chemists, and clinicians working together to rebuild the medicine-making process.
Hacker News (AI / LLM) files mainly under ai. We currently carry 7,595 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Isomorphiclabs |
| Canonical URL | https://www.isomorphiclabs.com/articles/building-a-new-path-to-make-medicines-with-ai |
| Publication time | Mon, 05 Oct 2026 02:32:27 +0000 |
| Retrieval time | 2026-10-05T02:42:14.915Z |
| Last seen | 2026-10-05T02:42:14.915Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | T_LexRN_1ltg · 1 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
The ScaleSolving all disease is one of the most monumentally complex challenges in science. Today, for the first time, AI provides the foundation to make it achievable.Tackling the frontier of human health is our mission, and it means identifying exactly where modern AI can make the greatest difference. We see drug discovery as the critical wedge in solving all disease, and therefore our initial focal point where AI can have a transformative impact on human health. Developing a drug that successfully and effectively treats disease fundamentally involves understanding biological mechanisms and designing exquisitely engineered molecules that can modulate them safely.So we are taking a straight shot at making that a reality.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Isomorphiclabs.
Discussion
0 commentsMore from Isomorphiclabs
